ResearcherFudan UniversityNo recent work listed
Jiaqi He
Matched on ORCID iD 0000-0003-2276-3298; OpenAlex author ID A5101981292. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation. Last author DOI 10.1515/med-2022-0433↗
- SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition. Co-author DOI 10.1093/abbs/gmy110↗
- CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer. Co-author DOI 10.18632/oncotarget.14037↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tongyi Zhang · 1 shared paper, 2022 · strength 0.22
- Chongyi Jiang · 2 shared papers, 2017–2018 · strength 0.14
- Paper SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mes… DOI 10.1093/abbs/gmy110↗
- Paper CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic … DOI 10.18632/oncotarget.14037↗
- Qiangsheng Hu · 1 shared paper, 2018 · strength 0.07
- Zhiwei Cai · 1 shared paper, 2018 · strength 0.07
- Xianjun Yu · 1 shared paper, 2018 · strength 0.07
- Pengfei Hu · 1 shared paper, 2018 · strength 0.07
- Wei Wang · 1 shared paper, 2018 · strength 0.07
- Yi Qin · 1 shared paper, 2018 · strength 0.07
- Sujie Ni · 1 shared paper, 2017 · strength 0.06
- Zhixian He · 1 shared paper, 2017 · strength 0.06
- Wei Ting Wang · 1 shared paper, 2017 · strength 0.06
- Xiaolin Zhu · 1 shared paper, 2017 · strength 0.06
- Chunhua Wan · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.